Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01555762
Other study ID # ML27829
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 5, 2012
Est. completion date July 20, 2016

Study information

Verified date February 2019
Source Hoffmann-La Roche
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This multicenter, prospective, observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in first-line therapy in elderly patients with metastatic colorectal cancer. Data will be collected from eligible patients for24 months.


Recruitment information / eligibility

Status Completed
Enrollment 402
Est. completion date July 20, 2016
Est. primary completion date July 20, 2016
Accepts healthy volunteers No
Gender All
Age group 75 Years and older
Eligibility Inclusion Criteria:

- Adult patients, >/= 75 years of age

- Metastatic colorectal cancer

- Initiating Avastin first-line therapy in combination with chemotherapy

Exclusion Criteria:

- Previous Avastin therapy

- Patient participating in a clinical study evaluating a cytotoxic anti-cancer therapy and/or an investigational new drug

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Ch D Abbeville; Medecine B1 Abbeville
France Ch D Agen; Medecine Interne II Agen
France Clinique Du Docteur Calabet; Cromg Agen
France C.H. Du Pays D'aix En Provence Service du Dr Blanc Aix En Provence
France Poly Parc Rambot La Provencale; Chimiotherapie Ambulatoire Aix En Provence
France Chd Castelluccio; Oncologie Ajaccio
France Clinique Claude Bernard; Onco Hematologie Albi
France Chi D Alencon; Medecine Ambulatoire Alencon
France Chi D Alencon; Medecine I Alencon
France Clinique De L Europe; Pmsi Amiens
France Clinique De L Europe; Radiotherapie Chimiotherapie Amiens
France Hopital Nord; Medecine A Amiens
France Centre Hospitalier de L'Agglomeration Montargeoise; Medecine Polyvalente A Orientation Mi & Cancero Amilly
France Cham; Medecine D Amilly
France Ctre Radiotherapie Et Onco Medic Amilly
France Hotel Dieu; Medecine A Angers
France Cabinet Medical Arras
France Centre Radiotherapie Marie Curie Arras
France Ch D Ardeche Meridionale; Medecine A2 Aubenas
France Ch D Auch; Med Interne Chimiotherapie Auch
France Clinique Sainte Catherine; Hopital De Semaine Avignon
France Clinique Du Docteur Maymard; Hopital De Jour Chimiotherapie Bastia
France Hopital De Falconaja Furiani; Hopital De Jour Bastia
France Centre Hospitalier de La Cote Basque; Oncologie Bayonne
France Centre Hospitalier; Hematologie-Oncologie Beauvais
France Hopital Jean Minjoz; Gastro Enterologie Besancon
France Hopital Jean Minjoz; Hopital de Jour Besancon
France HOPITAL JEAN MINJOZ; Oncologie Besancon
France Clinique Anne D Artois; Gastro Enterologie Bethune
France Clinique Champeau Mediterranee; Radiotherapie Oncologie Beziers
France Hopital Avicenne; Cancerologie Bobigny
France Clinique Tivoli; Sce Radiotherapie Bordeaux
France Polyclin Bordeaux Nord Aquitaine; Gastro Enterologie Bordeaux
France Centre Hospitalier Dr Duchenne; Hepato Gastro Enterologie Boulogne Sur Mer
France Centre Hospitalier Fleyriat; Oncologie/Hematologie Bourg En Bresse
France Ch De Fleyriat; Gastro Enterologie Bourg En Bresse
France Clinique Du Docteur Convert; Medecine Bourg En Bresse
France Clinique Pasteur Lanroze; Chimiotherapie Radiotherapie Brest
France Hopital Augustin Morvan; Federation De Cancerologie Brest
France CMC de Bligny; Hopital de Jour Briis Sous Forges
France CMC de Bligny; Oncologie Court Sejour Briis Sous Forges
France CMC de Bligny; Oncologie SSR Briis Sous Forges
France Ch De Brive La Gaillarde; Radiotherapie Oncologie Brive La Gaillarde
France Hopital Cote De Nacre; Gastro Enterologie Caen
France Infirmerie Protestante; Endos Digestive Coelioscopie Caluire Et Cuire
France Hopital Pierre Nouveau; Medecine A Cannes
France Ch Antoine Gayraud; Oncologie Carcassonne
France Clinique Montreal; Chimiotherapie Carcassonne
France Clinique Du Parc; Hematologie Castelnau Lez
France Cabinet Medical Challes Les Eaux
France Medipole De Savoie; Departement Oncologie Challes Les Eaux
France Oncologie 37; Bureau Chambray Les Tours
France Hopital Prive Paul d Egine; Chimiotherapie Ambulatoire Champigny Sur Marne
France Centre Hospitalier; Oncologie Chateauroux
France Ch De Cholet; Gastro Enterologie Cholet
France Pole Sante Republique;Oncologie Hematologie Clermont Ferrand
France Hopital Louis Pasteur; Medecine A Colmar
France Polyclinique Saint Come; Hopital De Jour Oncologie Compiegne
France CH Sud Francilien; Oncologie Corbeil-essonnes
France Ch Laennec; Medecine V Creil
France CHU Henri Mondor; Service d'Oncologie Medicale Creteil
France Ch De Dax; Radiotherapie Oncologie DAX
France Centre Leonard De Vinci;Chimiotherapie Dechy
France Centre Georges Francois Leclerc; Oncologie 3 Dijon
France Hopital Victor Jousselin; Gastro Enterologie Druex
France Centre D Oncologie Dunkerquois Dunkerque
France Chi Eure Seine D Evreux; Oncologie Conventionnelle Evreux
France Clinique Pasteur; Oncologie Medicale, Hematologie Evreux
France Ch Jacques Monod;Medecine A4 B4 Flers
France Chi De Frejus Saint Raphael; Hopital De Jour Frejus
France Hopital De Freyming; Secteur 1 Freyming Merlebach
France Chi Alpes Du Sud Site De Gap; Med Interne Et Polyvalente GAP
France Centre Gastro Loire Gien
France Hopital Nord Ouest;Gastro Enterologie Gleize
France CH Emmanuel Rain; Oncologie Gonesse
France Hopital Prive De Chantilly; Medecine Gouvieux Chantilly
France Hopital Alpha Sante De Hayange; Medecine B Hayange
France Clinique Sainte Marguerite; Oncologie Medicale Hyeres
France Polyclinique de Blois; Chimiotherapie Ambulatoire La Chaussee St Victor
France Centre Hospitalier Departemental Les Oudairies La Roche Sur Yon
France Centre Hospitalier Saint Louis; Oncologie Medicale La Rochelle
France Hopital Albert Michallon; Oncologie La Tronche
France Hopital Albert Michallon; Radiotherapie La Tronche
France Ch De Lagny Sur Marne; Oncologie Lagny Sur Marne
France Hopital Robert Boulin; Oncologie Libourne
France Polyclinique De La Louviere; Chimiotherapie Lille
France Polyclinique Du Bois; Oncologie Lille
France Ch De Longjumeau; Hopital De Jour Et Semaine Longjumeau
France Clinique Des 4 Pavillons; Chimiotherapie Lormont
France Clin Mut De Lyon Eugene Andre; Hopital De Jour 1er B Lyon
France Ctre Consultations La Sauvegarde Lyon
France Ctre Hosp St Joseph Et St Luc; Gastro Enterologie Endoscopie Lyon
France Hopital De La Croix Rousse;Hepato Gastro Entero Lyon
France Hopital Edouard Herriot; Pavillon E Oncologie Medicale Lyon
France Hopital Prive Jean Mermoz; Cancerologie Lyon
France Hopital Prive Jean Mermoz; Gastro Enterologie Hepatologie Lyon
France Clinique Saint Francois; Oncologie Medicale Mainvilliers
France CH Prive Clairval; Chimiotherapie Ambulatoire Marseille
France Clinique Mutualiste Bonneveine; Oncologie Medicale Marseille
France Hôpital Saint Joseph; Oncologie Medicale Marseille
France Hopital Timone Adultes; Oncologie Digestive Marseille
France Clinique Du Parc; Centre de Radiotherapie Gray Maubeuge
France Hopital Clinique Claude Bernard; Oncologie Medicale Metz
France Chra; Gastro Enterologie Metz Tessy
France Hopital Layne; Medecine A2 Mont De Marsan
France Hopital Layne; Medecine Ambulatoire Mont-de-marsan
France Ch De Montauban; Medecine Interne Montauban
France Site Le Mittan; Hopital De Jour Montbeliard
France Ch De Montelimar; Gastro Enterologie Oncologie Montelimar
France Ghi Le Raincy Montfermeil; Gastro Medecine Interne Montfermeil
France Ghi Le Raincy Montfermeil; Radiotherapie Oncologie Montfermeil
France Hopital Jacques Monod; Hopital De Semaine Unite 53 Montivilliers
France Clinique Clementville; Hopital De Jour Montpellier
France Hopital Saint Eloi; Hopital De Jour Montpellier
France Polyclinique Saint Roch; Hop Jour Chimio Radiotherapie Montpellier
France Centre Azureen De Cancerologie; Cons externes Mougins
France Clinique D Occitanie; Chimiotherapie Ambulatoire Muret
France Centre D'Oncologie de Gentilly; Oncology Nancy
France Polyclinique Gentilly; CHIMIOTHERAPIE AMBULATOIRE Nancy
France Polyclinique Du Languedoc; Chimiotherapie Narbonne
France Hopital Americain; Sce Oncologie Neuilly-sur-seine
France Ctre Radiotherapie Cyr Deguergue Nevers
France Centre Antoine Lacassagne; Hopital De Jour A2 Nice
France Hopital Caremeau; Gastro Enterologie Nimes
France Hopital Prive Armand Brillard; Groupe Sein Paris Est Nogent Sur Marne
France Polyclinique Des Murlins;Ambulatoire Orleans
France Clinique sainte marie; chimiotherapie ambulatoire Osny
France CH Pitie Salpetriere; Hepathologie Gastro Enterologie Paris
France GH Paris Saint Joseph; Hopital De Jour Oncologie Paris
France Hop Europeen Georges Pompidou; Gastro Enterologie Paris
France Hopital Bichat Claude Bernard; Hepatologie Gastro Enterologie Paris
France Hopital Des Diaconesses; Oncologie Paris
France Hopital Saint Antoine; Oncologie Medicale Paris
France HOPITAL TENON; Cancerologie Medicale Paris
France Clinique Francheville; Radiotherapie Perigueux
France Polyclinique Francheville; MED CHIMIOTHERAPIE RADIOTHERAPIE Perigueux
France Hopital Saint Jean; Hospitalisation Oncologie Perpignan
France Hopital Du Haut-Leveque; Gastro-Enterologie Pessac
France Ch Lyon Sud; Chir Visc Sect Jules Courmont Pierre Benite
France Ch Lyon Sud; Gastro Secteur Jules Courmont Pierre Benite
France Ctre Hosp Des Vals D Ardeche; Medecine C Privas
France Ch De Rambouillet; Medecine A2 Rambouillet
France Ch Arrondissement De Montreuil; Medecine 1 Rang du Fliers
France Centre Frederic Joliot Curie Rouen
France Ctre De Radiotherapie St Vincent Saint Gregoire
France Clinique de L'Union; Oncologie Saint Jean
France Ch De Selestat; Medecine A Selestat
France Centre Clinical; Oncologie Medicale Soyaux
France Hopital Yves Le Foll; Hematologie Oncologie St Brieuc
France Memorial France Etats Unis; Hopital De Jour St Lo
France Hopital Broussais; Medecine 2A St Malo
France Centre Joliot Curie St Martin Boulogne
France Ch De Saint Quentin; Gastro Enterologie Endoscopie St Quentin
France Clinique Chir De L Orangerie; Chimiotherapie Strasbourg
France Clinique Saint Anne; Hopital De Jour Strasbourg
France Fondation Maison Sante Bagatelle; Gastro Enterologie Talence
France Hopitaux Du Leman Site Thonon; Gastro Enterologie Thonon-les-bains
France Clinique Pasteur; Oncologie Medicale Toulouse
France Hopital Joseph Ducuing; Medecine Interne Toulouse
France Hopital Prive Du Vert Galant; Cons Specialisees Tremblay En France
France Ch De Valence; Medecine 6 Valence
France Clinique Oceane; Medecine B Vannes
France Gh Mutualiste Les Portes Du Sud; Gastro-Enterologie Venissieux
France Hopital Saint Nicolas; Medecine A Verdun
France Clinique De La Porte Verte; EST 3 Versailles
France Hopital Prive Villeneuve d Ascq;Chimiotherapie Radiotherapie Villeneuve D Ascq

Sponsors (1)

Lead Sponsor Collaborator
Hoffmann-La Roche

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Progression-Free Survival Progression was defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0), as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions. From the time of first dose of study treatment to the time of disease progression or death from any cause (Up to 53 months)
Secondary Overall Survival Overall survival was defined as the time between the treatment start date (date of the first infusion of bevacizumab) and date of all-cause death. From the time of first dose of study treatment to the time of death from any cause (Up to 53 months)
Secondary Percentage of Participants With Bevacizumab Administration Up to 36 months
Secondary Percentage of Participants With Adverse Events (AEs) An AE was considered any unfavorable and unintended sign, symptom, or disease associated with the use of the study drug, whether or not considered related to the study drug. Up to 53 months
Secondary Percentage of Participants With Activities of Daily Living (ADL) The Katz Activity of Daily Living (ADL) questionnaire scale contains 6 items evaluating in terms of autonomy or dependence the patient's ability to carry out basic activities of daily living (bathing, dressing, toileting, transfer, continence, feeding). Total score range 0 (low) to 6 (high). High score indicates participant is independent. Baseline, Month 6, 12, 24
Secondary Lawton Instrumental Activities of Daily Living Score (IADL) The Lawton Instrumental Activities of Daily Living Scale (IADL) is an appropriate instrument to assess independent living skills. The instrument is most useful for identifying how a participant is functioning at the present time and for identifying improvement or deterioration over time. There are 8 domains of function measured with the Lawton IADL scale (telephone use, shopping, cooking, housekeeping, laundry, mode of transportation, responsibility of own medications, and ability to handle finances). Participants are scored according to their level of functioning from 0 (low function, dependent) to 8 (high function, independent). Higher score for each domain represents better functional performance of the older people. Baseline, Month 6, 12, 24
Secondary Percentage of Participants With Balducci Score Balducci score defines an algorithm for the individual participant according to age, ADL and modified IADL 4-items scores, estimated performance status and comorbidities, particularly cardiovascular, cancer, depression or anemia. Balducci score is categorized in the following- Type 1 (Harmonious), Type 2 (Intermediate) and Type 3 (Frail). Type 1 indicates better results and Type 3 indicates worse outcomes. Baseline, Month 6, 12, 24
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A